| Date | Title | Description | Source |
| 20.03.2024 | Sosei Group Co., Ltd. Announcement of administration of EP4 ... | Sosei Group Co., Ltd.
Announcement of administration of first subject in Phase I clinical trial of E... | re-how.net... |
| 20.03.2024 | Sosei Group Co., Ltd. Completion of reacquisition of rights ... | Sosei Group Co., Ltd.
Completion of reacquisition of rights to HTL0027477, a first-class treatment c... | re-how.net... |
| 11.03.2024 | Boehringer Ingelheim and Sosei Heptares join forces to devel... | - | globenewsw... |
| 06.03.2024 | Sosei Heptares to receive US$2.5 million milestone payment f... | - | globenewsw... |
| 07.12.2023 | Sosei Group Co., Ltd. Approval for manufacturing and sales o... | Sosei Group Co., Ltd.
Approval for manufacturing and sales of Pivratz(R) Intravenous Injection 150mg... | re-how.net... |
| 11.11.2022 | Sosei Heptares Operational Highlights and Consolidated Resul... | /EIN News/ -- TOKYO and CAMBRIDGE, United Kingdom, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Sosei Group Cor... | einpresswi... |
| 10.02.2022 | Sosei : Consolidated Financial Results for the FY2021 (IFRS) | Consolidated Financial Results for the FY2021 (IFRS)
February 10, 2022
Company name: Sosei Group Cor... | marketscre... |
| 06.01.2022 | Sosei and Verily partner on GPCRs; ObsEva touts PhIII... | Sosei Heptares is teaming up with a big-name partner: Alphabet’s Verily.
No financials wer... | endpts.com... |
| 06.01.2022 | Verily, Sosei Heptares Collaborate to Generate Novel Drug Ca... | What You Should Know:
– Verily and Sosei Heptares announced a new research collaboration combining V... | hitconsult... |
| 24.12.2021 | Sosei Heptares Announces Antitrust Clearance of License Agre... | TOKYO, Japan and CAMBRIDGE, United Kingdom, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Sosei Group Corporatio... | marketscre... |
| 07.12.2021 | Sosei : Heptares Receives Grant Funding from Wellcome to Adv... | Funding comes through the Covid-19 Therapeutics Accelerator, which was set up by Wellcome, Bill &... | marketscre... |
| 26.11.2021 | Sosei : Investor Webinar Q&A - Collaboration with Neuroc... | NON - CONFIDENTIAL
Collaboration with Neurocrine Biosciences to Develop Novel Muscarinic Receptor Ag... | marketscre... |
| 22.11.2021 | Neurocrine Biosciences : and Sosei Heptares Announce Collabo... | Neurocrine Biosciences and Sosei Heptares Announce Collaboration to Develop Novel Muscarinic Recepto... | marketscre... |
| 22.11.2021 | Neurocrine Biosciences and Sosei Heptares Announce Collabora... | SAN DIEGO and TOKYO and CAMBRIDGE, England, Nov. 22, 2021 /PRNewswire/ -- Neurocrine Biosciences, In... | marketscre... |
| 17.11.2021 | Sosei : Jefferies London Healthcare Conference 2021 Presenta... | NON - CONFIDENTIAL
World leading drug discovery targeting GPCRs
Corporate Presentation
2021 | © Sose... | marketscre... |
| 16.11.2021 | Sosei : Heptares to present at the Jefferies London Healthca... | Tokyo, Japan and Cambridge, UK, 16 November 2021 - Sosei Group Corporation ("the Company";... | marketscre... |
| 11.11.2021 | Sosei Heptares Operational Highlights and Consolidated Resul... | PRESS RELEASE
Sosei Heptares Operational Highlights and Consolidated Results for Nine Months ended 3... | marketscre... |
| 11.11.2021 | Quarterly Report for the Third Quarter of 2021 (Quarter ende... | Sosei Group Corporation
Quarterly Report for the Third Quarter of 2021
(Quarter ended September 30, ... | marketscre... |
| 11.11.2021 | Consolidated Financial Results for the Nine Month Period End... | Consolidated Financial Results for the Nine Month Period Ended September 30, 2021 (IFRS)
November 11... | marketscre... |
| 12.08.2021 | Sosei : Heptares Operational Highlights and Consolidated Res... | Tokyo, Japan and Cambridge, UK, 12 August 2021 - Sosei Group Corporation ('the Company'; TSE: 4565) ... | marketscre... |
| 12.08.2021 | Sosei : H1 FY2021 Financial Results Presentation | NON-CONFIDENTIAL
H1 FY2021 Financial Results
Six-month period ended June 30, 2021
August 12, 2021 | ... | marketscre... |
| 08.07.2021 | Sosei : Announces Determination of the Issuance Terms for it... | PRESS RELEASE
Sosei Announces Determination of the Issuance Terms for its Convertible Bonds
Tokyo, J... | marketscre... |
| 07.07.2021 | Sosei : Announces Issuance of Convertible Bonds and Buyback ... | PRESS RELEASE
Sosei Announces Issuance of Convertible Bonds and Buyback of Existing Convertible Bond... | marketscre... |
| 23.06.2021 | Sosei : Heptares Initiates Phase 1 Trial with Novel Small-Mo... | PRESS RELEASE
Sosei Heptares Initiates Phase 1 Trial with Novel Small- Molecule CGRP Antagonist unde... | marketscre... |
| 04.06.2021 | SOSEI GROUP CORPORATION
Sosei : Notice Regarding Determinat... | PRESS RELEASE
Notice Regarding Determination of Payment Amount and Other Matters of Issuance of New ... | marketscre... |
| 19.05.2021 | SOSEI GROUP CORPORATION
Sosei : Heptares announces that the... | PRESS RELEASE
Sosei Heptares announces that the third novel drug candidate from its multi-target dru... | marketscre... |
| 19.05.2021 | SOSEI GROUP CORPORATION
Sosei Heptares : announces that the... | TOKYO and CAMBRIDGE, England, May 19, 2021 /PRNewswire/ -- Sosei Group Corporation ("the Compan... | marketscre... |
| 12.05.2021 | SOSEI GROUP CORPORATION
Sosei : Heptares Operational Highli... | PRESS RELEASE
Sosei Heptares Operational Highlights and Consolidated Results for the First Quarter 2... | marketscre... |
| 12.05.2021 | Sosei : Heptares Operational Highlights and Consolidated Res... | PRESS RELEASE
Sosei Heptares Operational Highlights and Consolidated Results for the First Quarter 2... | marketscre... |
| 12.05.2021 | Sosei : Consolidated Financial Results for the Three Months ... | Consolidated Financial Results for the Three Months Ended March 31, 2021 (IFRS)
May 12, 2021
Company... | marketscre... |
| 12.05.2021 | SOSEI GROUP CORPORATION
Sosei : Consolidated Financial Resu... | Consolidated Financial Results for the Three Months Ended March 31, 2021 (IFRS)
May 12, 2021
Company... | marketscre... |
| 21.04.2021 | SOSEI GROUP CORPORATION
Sosei : Notice of Issuance of New S... | PRESS RELEASE
Notice of Issuance of New Shares Under Restricted Stock Unit (RSU) Plan
Tokyo, Japan a... | marketscre... |
| 01.04.2021 | SOSEI GROUP CORPORATION
Sosei : Notice of Issuance of New S... | PRESS RELEASE
Notice of Issuance of New Shares Under Restricted Stock Unit (RSU) Plan
Tokyo, Japan a... | marketscre... |
| 16.02.2021 | Sosei Heptares : spin-off company Orexia Therapeutics merged... | TOKYO and CAMBRIDGE, England, Feb. 16, 2021 /PRNewswire/ -- Sosei Group Corporation ("the Compa... | marketscre... |
| 16.02.2021 | Sosei Heptares spin-off company Orexia Therapeutics merged i... | TOKYO and CAMBRIDGE, England, Feb. 16, 2021 /PRNewswire/ -- Sosei Group Corporation ("the Compa... | salamancap... |
| 12.01.2021 | Sosei Heptares and PharmEnable collaborate for AI-driven dru... | Sosei Heptares and PharmEnable collaborate for AI-driven drug discovery against challenging GPCR tar... | cambridgen... |
| 05.01.2021 | AbbVie bails on Sosei Heptares pact for novel neurolo... | Japan’s Sosei Heptares has built a who’s who list of big-name partners looking to license the c... | endpts.com... |
| 22.12.2020 | SOSEI GROUP CORPORATION
Sosei Heptares : and Captor Therape... | TOKYO and CAMBRIDGE, England, Dec. 22, 2020 /PRNewswire/ -- Sosei Group Corporation ("the Compa... | marketscre... |
| 22.12.2020 | Sosei Heptares : and Captor Therapeutics Enter Strategic Tec... | TOKYO and CAMBRIDGE, England, Dec. 22, 2020 /PRNewswire/ -- Sosei Group Corporation ("the Compa... | marketscre... |
| 13.08.2020 | SOSEI GROUP CORPORATION
Sosei : Consolidated Financial Resu... | Consolidated Financial Results for the Six Months Ended June 30, 2020 (IFRS)
August 13, 2020
Company... | marketscre... |
| 13.08.2020 | SOSEI GROUP CORPORATION
Sosei : Heptares Operational Highli... | PRESS RELEASE
Sosei Heptares Operational Highlights and Consolidated Results for the First Half 2020... | marketscre... |
| 16.07.2020 | SOSEI GROUP CORPORATION
Sosei Heptares : Successfully Raise... | TOKYO and LONDON, July 16, 2020 /PRNewswire/ -- Sosei Group Corporation ("the Company") (T... | marketscre... |
| 25.06.2020 | Back to the immunology drawing board, AbbVie inks dis... | Allergan’s neurology-focused R&D pact with Sosei Heptares hasn’t been all roses, but th... | endpts.com... |
| 25.06.2020 | AbbVie, Sosei Heptares enter $409M deal to discover, develop... | “Collaborating with leading pharmaceutical companies is a core element of our successful value-gener... | medcitynew... |
| - | ‘Truly Transformational:’ Sosei Heptares Acquires Idorsia’s ... | Sosei Heptares has announced its acquisition for U.S.$466 million (JPY 65 billion) of Idorsia’s phar... | orrick.com... |
| - | AbbVie, Sosei Heptares enter $409M deal to discover, develop... | A Japanese firm that had previously partnered with a company acquired last year by AbbVie is now par... | medcitynew... |
